Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs and weak US business. He suggests Sun Pharma and Cipla as resilient options ...

"Excellent finish to the year with strong growth and high profitability" Fourth quarter and full year summary October - December Total revenues grew 48% (44% at CER1) to SEK 553 (375) million Sales ...

Live” marks its 50th anniversary, The Canadian Press looks back on some of the sketch comedy show’s most notable Canadian ...

In announcing his desire to impose reciprocal tariffs, Trump has not spared anyone — neither enemies nor allies — and has, as ...